StonvexLoading…
StonvexStonvexStonvexCore line items from CASY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $12.99B | $9.07B | $4.57B | $15.94B |
Operating Income | $723.90M | $552.45M | $278.46M | Not available |
Net Income | $551.76M | $206.34M | $215.35M | $546.52M |
EPS (Diluted) | $14.79 | $11.29 | $5.77 | $14.64 |
Total Assets | $8.59B | $8.59B | $8.37B | $8.21B |
Total Liabilities | $4.73B | $4.78B | $4.73B | $4.70B |
Cash & Equivalents | $465.02M | $492.02M | $458.07M | $326.66M |
Free Cash Flow OCF − CapEx | $514.19M | $438.39M | $262.37M | $584.63M |
Shares Outstanding | 37.31M | 37.34M | 37.35M | 37.34M |